Oragenics, Inc. (OGEN) vs Silo Pharma, Inc. (SILO)

Oragenics, Inc. and Silo Pharma, Inc. are both Biotechnology companies. Oragenics, Inc. and Silo Pharma, Inc. are of similar size ($2.0M and $1.9M). Silo Pharma, Inc. has negative trailing earnings, so its P/E is not meaningful; Oragenics, Inc. trades at 0.4×. Silo Pharma, Inc. grew revenue faster over the last twelve months: 0.00% against −75.1%. Across the 13 metrics below, Silo Pharma, Inc. leads on 8 and Oragenics, Inc. on 5.

Valuation

Metric OGEN SILO Biotechnology median
P/E 0.38 n/m 8.50
P/S 15.40 18.00 9.71
P/B 0.52 0.27 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 0.90 0.64
EV/Sales 3.56 (54.56) 9.21
Earnings yield 259.93% (369.34%) (33.15%)
Free cash flow yield (534.75%) (302.55%) (25.50%)

Profitability

Metric OGEN SILO Biotechnology median
Gross margin 19.89% 11.81% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (1,307.07%) (91.23%) (56.36%)
Return on assets (264.23%) (70.96%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric OGEN SILO Biotechnology median
Revenue growth (TTM) (75.08%) 0.00% 6.02%
EPS growth (last fiscal year) 90.51% 57.98% 30.26%
Revenue growth, 5-year CAGR (50.98%) 12.17% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric OGEN SILO Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.01 5.36 4.72
Net debt to EBITDA 0.98 1.61 0.96

Dividend

Metric OGEN SILO Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric OGEN SILO Biotechnology median
Market cap 1.97m 1.91m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack